Quick Answer
HUTCHMED (China) Ltd reported Revenue (ASC 606) of $548.51 million for fiscal year 2025.
HUTCHMED (China) Ltd Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $548.51M | -13.0% |
| 2024 | $630.20M | -24.8% |
| 2023 | $838.00M | +96.5% |
| 2022 | $426.41M | +19.7% |
| 2021 | $356.13M | +56.2% |
| 2020 | $227.98M | +11.3% |
| 2019 | $204.89M | -4.3% |
| 2018 | $214.11M | -11.2% |
| 2017 | $241.20M | +11.6% |
| 2016 | $216.08M | — |
- HUTCHMED (China) Ltd showed a decrease of -13.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, HUTCHMED (China) Ltd’s revenue (asc 606) has grown by 153.8% (from $216.08 million to $548.51 million).
- The most recent figure is from HUTCHMED (China) Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: